Annual CFI
$4.78 M
+$3.18 M+199.03%
December 31, 2023
Summary
- As of February 7, 2025, PTIX annual cash flow from investing activities is $4.78 million, with the most recent change of +$3.18 million (+199.03%) on December 31, 2023.
- During the last 3 years, PTIX annual CFI has risen by +$4.78 million (+100.00%).
- PTIX annual CFI is now -73.12% below its all-time high of $17.77 million, reached on December 31, 2008.
Performance
PTIX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
-$1.60 M-100.00%
September 30, 2024
Summary
- As of February 7, 2025, PTIX quarterly cash flow from investing activities is $0.00, with the most recent change of -$1.60 million (-100.00%) on September 30, 2024.
- Over the past year, PTIX quarterly CFI has dropped by -$1.60 million (-100.00%).
- PTIX quarterly CFI is now -100.00% below its all-time high of $12.93 million, reached on March 31, 2008.
Performance
PTIX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$5.08 M
-$590.70 K-10.41%
September 30, 2024
Summary
- As of February 7, 2025, PTIX TTM cash flow from investing activities is $5.08 million, with the most recent change of -$590.70 thousand (-10.41%) on September 30, 2024.
- Over the past year, PTIX TTM CFI has dropped by -$590.70 thousand (-10.41%).
- PTIX TTM CFI is now -71.40% below its all-time high of $17.77 million, reached on December 31, 2008.
Performance
PTIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PTIX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +199.0% | -100.0% | -10.4% |
| 3 y3 years | +100.0% | -100.0% | -10.4% |
| 5 y5 years | +356.7% | -100.0% | -10.4% |
PTIX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.2% | -100.0% | at low | -10.6% | +151.3% |
| 5 y | 5-year | at high | +148.2% | -100.0% | +100.0% | -10.6% | +148.9% |
| alltime | all time | -73.1% | +148.2% | -100.0% | +100.0% | -71.4% | +148.9% |
Protagenic Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $5.08 M(-10.4%) |
| Jun 2024 | - | $1.60 M(+33.0%) | $5.67 M(-0.2%) |
| Mar 2024 | - | $1.20 M(-47.2%) | $5.68 M(+19.0%) |
| Dec 2023 | $4.78 M(+199.0%) | $2.28 M(+285.7%) | $4.78 M(+79.6%) |
| Sep 2023 | - | $590.70 K(-63.4%) | $2.66 M(+9.6%) |
| Jun 2023 | - | $1.61 M(+447.0%) | $2.43 M(+59.5%) |
| Mar 2023 | - | $294.70 K(+82.1%) | $1.52 M(-4.8%) |
| Dec 2022 | $1.60 M(-116.1%) | $161.80 K(-54.7%) | $1.60 M(-16.9%) |
| Sep 2022 | - | $357.50 K(-49.4%) | $1.92 M(-121.8%) |
| Jun 2022 | - | $706.90 K(+90.6%) | -$8.83 M(-7.4%) |
| Mar 2022 | - | $370.80 K(-23.7%) | -$9.54 M(-3.7%) |
| Dec 2021 | -$9.91 M(<-9900.0%) | $485.90 K(-104.7%) | -$9.91 M(-4.7%) |
| Sep 2021 | - | -$10.40 M(<-9900.0%) | -$10.40 M(<-9900.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2019 | $250.00 K(-76.1%) | $0.00(0.0%) | $250.00 K(-49.5%) |
| Sep 2019 | - | $0.00(0.0%) | $495.50 K(-41.9%) |
| Jun 2019 | - | $0.00(-100.0%) | $853.00 K(-21.8%) |
| Mar 2019 | - | $250.00 K(+1.8%) | $1.09 M(+4.3%) |
| Dec 2018 | $1.05 M(-181.3%) | $245.50 K(-31.3%) | $1.05 M(+56.9%) |
| Sep 2018 | - | $357.50 K(+50.7%) | $666.40 K(-32.4%) |
| Jun 2018 | - | $237.30 K(+15.6%) | $985.30 K(-191.1%) |
| Mar 2018 | - | $205.30 K(-253.6%) | -$1.08 M(-16.0%) |
| Dec 2017 | -$1.29 M(<-9900.0%) | -$133.70 K(-119.8%) | -$1.29 M(+11.6%) |
| Sep 2017 | - | $676.40 K(-137.0%) | -$1.15 M(-37.0%) |
| Jun 2017 | - | -$1.83 M(<-9900.0%) | -$1.83 M(<-9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $0.00(0.0%) | -$1000.00(0.0%) |
| Jun 2015 | -$1000.00(0.0%) | $0.00(-100.0%) | -$1000.00(0.0%) |
| Mar 2015 | - | -$1000.00(<-9900.0%) | -$1000.00(<-9900.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2014 | -$1000.00(-106.7%) | $0.00(0.0%) | -$1000.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | -$1000.00(0.0%) |
| Dec 2013 | - | $0.00(-100.0%) | -$1000.00(0.0%) |
| Sep 2013 | - | -$1000.00(-99.5%) | -$1000.00(-99.8%) |
| Jun 2013 | $15.00 K(-97.8%) | - | - |
| Sep 2011 | - | -$220.00 K(+349.0%) | -$551.00 K(-2219.2%) |
| Jun 2011 | - | -$49.00 K(-92.4%) | $26.00 K(-60.6%) |
| Mar 2011 | - | -$642.00 K(-278.3%) | $66.00 K(-90.3%) |
| Dec 2010 | $679.00 K | $360.00 K(+0.8%) | $679.00 K(+117.6%) |
| Sep 2010 | - | $357.00 K(-4066.7%) | $312.00 K(-123.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | -$9000.00(-69.0%) | -$1.35 M(+18.8%) |
| Mar 2010 | - | -$29.00 K(+314.3%) | -$1.14 M(-148.2%) |
| Dec 2009 | $2.37 M(-86.7%) | -$7000.00(-99.5%) | $2.37 M(+6.6%) |
| Sep 2009 | - | -$1.31 M(-738.5%) | $2.22 M(-22.5%) |
| Jun 2009 | - | $205.00 K(-94.1%) | $2.86 M(-65.6%) |
| Mar 2009 | - | $3.48 M(-2357.8%) | $8.32 M(-53.2%) |
| Dec 2008 | $17.77 M(-442.7%) | -$154.00 K(-76.8%) | $17.77 M(+21.4%) |
| Sep 2008 | - | -$665.00 K(-111.8%) | $14.64 M(+0.8%) |
| Jun 2008 | - | $5.66 M(-56.2%) | $14.52 M(+85.4%) |
| Mar 2008 | - | $12.93 M(-493.8%) | $7.83 M(-251.1%) |
| Dec 2007 | -$5.18 M(+2492.0%) | -$3.28 M(+321.9%) | -$5.18 M(+172.6%) |
| Sep 2007 | - | -$778.00 K(-24.6%) | -$1.90 M(+69.2%) |
| Jun 2007 | - | -$1.03 M(+1021.7%) | -$1.12 M(+1552.9%) |
| Mar 2007 | - | -$92.00 K(<-9900.0%) | -$68.00 K(<-9900.0%) |
| Dec 2006 | -$200.00 K(<-9900.0%) | - | - |
| Oct 2006 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Jul 2006 | - | $24.00 K(-200.0%) | $0.00(-100.0%) |
| Jul 2006 | $0.00(0.0%) | - | - |
| Apr 2006 | - | -$24.00 K(<-9900.0%) | -$24.00 K(<-9900.0%) |
| Jan 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2005 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Jul 2005 | $0.00(-100.0%) | - | - |
| Jul 2004 | $6.43 M(-460.9%) | - | - |
| Apr 2003 | - | -$140.00 K(-78.9%) | -$1.70 M(-10.9%) |
| Jan 2003 | - | -$665.00 K(+91.6%) | -$1.91 M(+12.4%) |
| Oct 2002 | - | -$347.00 K(-36.7%) | -$1.70 M(-4.8%) |
| Jul 2002 | -$1.78 M(-8.6%) | -$548.00 K(+57.0%) | -$1.78 M(-0.5%) |
| Apr 2002 | - | -$349.00 K(-23.1%) | -$1.79 M(-6.1%) |
| Jan 2002 | - | -$454.00 K(+5.1%) | -$1.91 M(+0.8%) |
| Oct 2001 | - | -$432.00 K(-22.4%) | -$1.89 M(-2.9%) |
| Jul 2001 | -$1.95 M(+17.3%) | -$557.00 K(+19.5%) | -$1.95 M(+3.4%) |
| Apr 2001 | - | -$466.00 K(+6.2%) | -$1.89 M(-0.2%) |
| Jan 2001 | - | -$439.00 K(-10.0%) | -$1.89 M(+2.1%) |
| Oct 2000 | - | -$488.00 K(-1.0%) | -$1.85 M(+11.3%) |
| Jul 2000 | -$1.66 M(-8.4%) | -$493.00 K(+4.9%) | -$1.66 M(-1.3%) |
| Apr 2000 | - | -$470.00 K(+17.5%) | -$1.69 M(+11.2%) |
| Jan 2000 | - | -$400.00 K(+33.3%) | -$1.51 M(-11.7%) |
| Oct 1999 | - | -$300.00 K(-41.7%) | -$1.72 M(-5.5%) |
| Jul 1999 | -$1.81 M(-51.3%) | -$515.00 K(+71.7%) | -$1.81 M(+4.9%) |
| Apr 1999 | - | -$300.00 K(-50.0%) | -$1.73 M(+6.1%) |
| Jan 1999 | - | -$600.00 K(+50.0%) | -$1.63 M(-56.3%) |
| Oct 1998 | - | -$400.00 K(-7.0%) | -$3.73 M(0.0%) |
| Jul 1998 | -$3.73 M(+148.7%) | -$430.00 K(+115.0%) | -$3.73 M(+13.0%) |
| Apr 1998 | - | -$200.00 K(-92.6%) | -$3.30 M(+6.5%) |
| Jan 1998 | - | -$2.70 M(+575.0%) | -$3.10 M(+675.0%) |
| Oct 1997 | - | -$400.00 K | -$400.00 K |
| Jul 1997 | -$1.50 M | - | - |
FAQ
- What is Protagenic Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual CFI year-on-year change?
- What is Protagenic Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly CFI year-on-year change?
- What is Protagenic Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Protagenic Therapeutics?
- What is Protagenic Therapeutics TTM CFI year-on-year change?
What is Protagenic Therapeutics annual cash flow from investing activities?
The current annual CFI of PTIX is $4.78 M
What is the all time high annual CFI for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual cash flow from investing activities is $17.77 M
What is Protagenic Therapeutics annual CFI year-on-year change?
Over the past year, PTIX annual cash flow from investing activities has changed by +$3.18 M (+199.03%)
What is Protagenic Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PTIX is $0.00
What is the all time high quarterly CFI for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly cash flow from investing activities is $12.93 M
What is Protagenic Therapeutics quarterly CFI year-on-year change?
Over the past year, PTIX quarterly cash flow from investing activities has changed by -$1.60 M (-100.00%)
What is Protagenic Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PTIX is $5.08 M
What is the all time high TTM CFI for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM cash flow from investing activities is $17.77 M
What is Protagenic Therapeutics TTM CFI year-on-year change?
Over the past year, PTIX TTM cash flow from investing activities has changed by -$590.70 K (-10.41%)